To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response

Published:2020-01 Issue: Volume:85 Page:102702
ISSN:1568-7864
Container-title:DNA Repair
language:en
Short-container-title:DNA Repair

Author:

Liu Qi,Gao Jinlan,Zhao Chenyang,Guo Yingying,Wang Shiquan,Shen Fei,Xing Xuesha,Luo Yang

Funder

National Natural Science Foundation of China

Foundation of Liaoning Educational Committee

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference136 articles.

1. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015

2. Global control of cell-cycle transcription by coupled CDK and network oscillators;Orlando;Nature,2008

3. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication;Sørensen;Nucleic Acids Res.,2012

4. Wee1 and Cdc25: tools, pathways, mechanisms, questions;Moseley;Cell Cycle,2017

5. Cdk2 dethroned as master of S phase entry;Hinds;Cancer Cell,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023);Pharmaceutical Fronts;2024-09-03

2. MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer;Cancer Research Communications;2024-09-01

3. Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity;Bioorganic Chemistry;2024-06

4. Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers;International Journal of Molecular Sciences;2024-05-06

5. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma;Pharmaceutics;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3